Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zim LaboratoriesNSE:ZIMLAB +7.11%82 3-Year Book Growth Rate is 10.40% as of Jun. 2026, which is at its 10-year median of 10.40. GuruFocus rates NSE:ZIMLAB with a GF Score™ of 82/100 and a GF Value™ of ₹112.81 (Fairly Valued). The stock has 7 warning signs investors should review. Among 909 Drug Manufacturers companies, Zim Laboratories ranks better than 71.18% on this metric.
During the past 12 months, Zim Laboratories's average Book Value per Share Growth Rate was 6.90% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 10.40% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 11.60% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 9.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 12 years, the highest 3-Year average Book Value per Share Growth Rate of Zim Laboratories was 15.20% per year. The lowest was 4.90% per year. And the median was 10.40% per year.
Zim Laboratories (NSE:ZIMLAB) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Zim Laboratories 3-Year Book Growth Rate Related Terms
NSE:ZIMLAB vs ZTS: 3-Year Book Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Zim Laboratories's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zim Laboratories 3-Year Book Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zim Laboratories's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Zim Laboratories's 3-Year Book Growth Rate falls into.
Zim Laboratories 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 10.40% mean?
Zim Laboratories (NSE:ZIMLAB) has a 3-Year Book Growth Rate of 10.40% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Zim Laboratories and its competitors. This is near median its historical median of 10.40. Over the past decade, Zim Laboratories' 3-Year Book Growth Rate has ranged from 4.90 to 15.20. According to the industry distribution chart, Zim Laboratories ranks #262 out of 909 companies in the Drug Manufacturers industry, placing it in the top 28.8%.
Is Zim Laboratories' 3-Year Book Growth Rate too high?
Zim Laboratories' current 3-Year Book Growth Rate of 10.40% is near median its 10-year median of 10.40. Over the past 10 years, this metric has ranged from a low of 4.90 to a high of 15.20. The Drug Manufacturers industry median 3-Year Book Growth Rate is 4.70. Zim Laboratories' value of 10.40% is 121.3% above this industry median. Based on the distribution chart, Zim Laboratories ranks #262 out of 909 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Zim Laboratories has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zim Laboratories' 3-Year Book Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zim Laboratories ranks #262 out of 909 companies for 3-Year Book Growth Rate. This puts Zim Laboratories in the upper half of its industry. The industry median 3-Year Book Growth Rate is 4.70. Zim Laboratories' value of 10.40% is 121.3% above this benchmark. Historically, Zim Laboratories' own 3-Year Book Growth Rate has ranged from 4.90 to 15.20 over the past decade. While the company's 10-year median is 10.40 vs. the industry median of 4.70, Zim Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Drug Manufacturers company?
The median 3-Year Book Growth Rate among Drug Manufacturers companies is 4.70, based on 909 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zim Laboratories's current 3-Year Book Growth Rate of 10.40% is 121.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Zim Laboratories and its competitors. For the Drug Manufacturers industry, the median 3-Year Book Growth Rate is 4.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zim Laboratories's current 3-Year Book Growth Rate is 10.40%, which is near median its own 10-year median of 10.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zim Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Zim Laboratories (NSE:ZIMLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹112.81, compared to a current price of ₹115.20 — trading 2.1% above its estimated fair value. The current 3-Year Book Growth Rate is 10.40%, which is near median its 10-year median of 10.40 and 121.3% above the Drug Manufacturers industry median of 4.70. Zim Laboratories' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Zim Laboratories (NSE:ZIMLAB), the current 3-Year Book Growth Rate is 10.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zim Laboratories (NSE:ZIMLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Zim Laboratories stock appears to be overvalued.
The current stock price of ₹115.20 is trading 2.1% above its estimated GF Value™ of ₹112.81.
GuruFocus considers Zim Laboratories to be Fairly Valued.
Key valuation signals for NSE:ZIMLAB:
3-Year Book Growth Rate: 10.40% (near median its 10-year median of 10.40)
GF Value™: ₹112.81 vs. price of ₹115.20 (2.1% above fair value)
Industry Position: 121.3% above the Drug Manufacturers median (#262 of 909)
No single metric tells the full story. See the NSE:ZIMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zim Laboratories Ltd is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. It is engaged in manufacturing &wholesale of pharmaceutical products, market research and research & development activities. The Group is mainly engaged in the business of pharmaceuticals. It has presence in India and Outside India. The company generates majority of revenue from India. Its products are Oral Thin Films, Pre-formulations Intermediates, Finished Formulations.
82GF Score
Get the complete analysis for NSE:ZIMLAB
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ZIMLAB has been successfully added to your 
